The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


US Auto Industry Urges Trump to Block Chinese EV Market Access
ECB Signals Possible Interest Rate Move if Inflation Outlook Fails to Improve
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump
Rubio Discusses Iran Crisis and Strait of Hormuz Disruptions With UK and Australia
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
US Inflation Expected to Rise Again in April as Fed Signals Higher Interest Rates
AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher
Why the future of marijuana legalization remains hazy despite high public support
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 



